Job/Unit: O50968
/KAP1
Date: 24-09-15 11:33:27
Pages: 8
Reactions of Thioacetamide Derivatives with Sulfonyl Azides
–
1
+
(
8
CN) cm . MS (EI): m/z (%) = 307 [M] (2), 152 (100), 91 (46), NMR ([D
6
]DMSO): δ = 3.30–3.35 (m, 2 H, CH
), 3.47–3.49 (m, 2 H, CH ), 3.64–3.66 (m, 2 H, CH
(s, 2 H, CH ), 7.20–7.29 (m, 5 H, ArH), 7.74–7.77 (m, 1 H, ArH),
.18–8.21 (m, 2 H, ArH) ppm. C NMR (CDCl
47.1, 66.1, 125.5, 127.2, 127.8, 128.1, 129.0, 129.1, 133.6, 135.0,
50.0, 155.6, 165.5 ppm. MS (EI): m/z (%) = 402 [M]+ (10), 338
13), 135 (53), 86 (100). C18 (402.49): calcd. C 53.71, H
.51, N 13.92; found C 53.42, H 4.45, N 13.71.
2
), 3.41–3.43 (m, 2
+
6 (46). MS (ESI): m/z = 308 [M + H] . C14
calcd. C 54.72, H 5.53, N 13.68; found C 54.56, H 5.69, N 13.47.
H
17
N
3
O
3
S (307.37):
H, CH
2
2
2
), 4.58
2
1
3
8
3
): δ = 37.2, 45.3,
N-[2-Cyano-1-(pyrrolidin-1-yl)ethylidene]-4-methylbenzenesulfon-
amide (10b): Colorless powder (80%), m.p. 118–120 °C. H NMR
1
1
(
4
(
[D
CH
8.0 Hz, 2 H, CH
ArH), 7.70 (d, J = 8.0 Hz, 2 H, ArH) ppm. C NMR ([D
DMSO): δ = 20.2, 21.5, 24.1, 25.8, 48.3, 49.7, 112.9, 126.4, 129.4,
6
]DMSO): δ = 1.89–1.94 (m, 2 H, CH
), 2.40 (s, 3 H, CH ), 3.45 (t, J = 8.0 Hz, 2 H, CH
), 4.30 (s, 2 H, CH ), 7.30 (d, J = 8.0 Hz, 2 H,
2
), 1.97–2.04 (m, 2 H,
18 4 3 2
H N O S
2
3
2
), 3.68 (t, J
=
2
2
1
3
6
]-
N-[2-(4-Chlorophenyl)-1-morpholinoethylidene]methanesulfonamide
1
(10i): Colorless powder (85%), m.p. 127–129 °C. H NMR ([D ]-
DMSO): δ = 2.97 (s, 3 H, CH ), 3.30–3.40 (m, 4 H, CH ), 3.57–
6
–1
1
(
(
40.2, 142.7, 153.3 ppm. IR: ν˜ = 2254 (CN) cm . MS (EI): m/z
%) = 291 [M]+ (5), 136 (48), 91 (48), 70 (100). C14
291.37): calcd. C 57.71, H 5.88, N 14.42; found C 57.51, H 5.61,
3
2
H
17
N
3
O
2
S
2 2 2
3.60 (m, 2 H, CH ), 3.67–3.75 (m, 2 H, CH ), 4.39 (s, 2 H, CH ),
7.31 (d, J = 8.0 Hz, 2 H, ArH), 7.40 (d, J = 8.0 Hz, 2 H, ArH)
1
3
N, 14.23.
6
ppm. C NMR ([D ]DMSO): δ = 35.0, 43.4, 44.4, 46.5, 66.0,
1
29.0, 131.0, 131.3, 134.0, 164.2 ppm. MS (EI): m/z (%) = 316
2
-Cyano-NЈ-tosylacetimidamide (10c): Colorless powder (92 %),
+
1
2 3
[M] (25), 150 (100), 125 (44), 79 (21). C13H17ClN O S (316.80):
calcd. C 49.29, H 5.41, N 8.84; found C 49.49, H 5.64, N 9.03.
m.p. 128–130 °C. H NMR ([D
6
]DMSO): δ = 2.38 (s, 3 H, CH
3
),
3
8
.80 (s, 2 H, CH
.0 Hz, 2 H, ArH), 8.13 (s, 1 H, NH), 8.86 (s, 1 H, NH) ppm.
]DMSO): δ = 20.9, 26.1, 115.8, 126.3, 130.1, 139.7,
2
), 7.37 (d, J = 8.0 Hz, 2 H, ArH), 7.75 (d, J =
1
3
C
N-[2-(4-Chlorophenyl)-1-morpholinoethylidene]-4-methylbenzene-
sulfonamide (10j): Colorless powder (92%), m.p. 130–132 °C.
NMR ([D ]DMSO): δ = 2.36 (s, 3 H, CH ), 3.30–3.37 (m, 4 H,
6 3
1
NMR ([D
6
H
–1
143.2, 154.9 ppm. IR: ν˜ = 2254 (CN) cm . MS (EI): m/z (%) =
2
37 [M]+ (19), 155 (36), 91 (100), 65 (28). C10
11 3 2
H N O
S (237.28): CH ), 3.56–3.58 (m, 2 H, CH ), 3.67–3.70 (m, 2 H, CH ), 4.43 (s,
2
2
2
calcd. C 50.62, H 4.67, N 17.71; found C 50.43, H 4.61, N 17.97.
2 H, CH ), 7.22 (d, J = 8.0 Hz, 2 H, ArH), 7.30 (d, J = 8.0 Hz, 2
2
H, ArH), 7.38 (d, J = 8.0 Hz, 2 H, ArH), 7.69 (d, J = 8.0 Hz, 2 H,
N-(4-Chlorophenyl)-2-cyano-NЈ-tosylacetimidamide (10d): Pale yel-
1
3
1
ArH) ppm. C NMR ([D
6
]DMSO): δ = 21.6, 35.2, 45.2, 47.3, 66.0,
low powder (85%), m.p. 132–134 °C. H NMR ([D
6
]DMSO): δ =
1
26.3, 129.1, 129.7, 130.3, 131.8, 134.0, 141.6, 142.3, 164.8 ppm.
2
7
1
1
.39 (s, 3 H, CH
3 2
), 4.20 (s, 2 H, CH ), 7.38–7.46 (m, 4 H, ArH),
+
MS: m/z (%) = 393 [M] (2), 155 (79), 91 (100), 86 (66).
21ClN S (392.90): calcd. C 58.08, H 5.39, N 7.13; found C
7.87, H 5.20, N 7.09.
.57 (d, J = 8.0 Hz, 2 H, ArH), 7.78 (d, J = 8.0 Hz, 2 H, ArH),
0.92 (s, 1 H, NH) ppm. 1 C NMR ([D
3
C
5
19
H
2 3
O
6
]DMSO): δ = 20.7, 22.7,
14.8, 123.3, 125.9, 128.9, 129.5, 136.2, 139.6, 142.8, 153.7 ppm.
–1
+
IR: ν˜ = 2254 (CN) cm . MS (EI): m/z (%) = 347 [M] (7), 155
33), 91 (100), 65 (28). C16 14ClN S (347.82): calcd. C 55.25, H
.06, N 12.08; found C 55.12, H 3.86, N 12.17.
N-[2-(4-Chlorophenyl)-1-morpholinoethylidene]-2,4-dimethyl-
(
4
H
3 2
O
benzenesulfonamide (10k): Colorless powder (68 %), m.p. 120–
1
1
CH
22 °C. H NMR (CDCl
3
): δ = 2.36 (s, 3 H, CH
), 3.60–3.70 (m, 2 H, CH
3.85 (m, 2 H, CH ), 4.41 (s, 2 H, CH ), 7.02 (d, J = 8.0 Hz, 2 H,
3
), 2.70 (s, 3 H,
), 3.30–3.42 (m, 4 H, CH
2
2
), 3.70–
N-(1-Morpholino-2-phenylethylidene)methanesulfonamide (10e):
3
1
Colorless powder (60%), m.p. 85–88 °C. H NMR ([D
2.96 (s, 3 H, CH ), 3.23–3.41 (m, 4 H, CH ), 3.55–3.65 (m, 2 H,
CH ), 3.67–3.75 (m, 2 H, CH ), 4.39 (s, 2 H, CH ), 7.21–7.31 (m,
H, ArH), 7.34 (d, J = 8.0 Hz, 2 H, ArH) ppm. C NMR ([D
DMSO): δ = 36.3, 44.0, 44.9, 47.0, 66.0, 126.9, 128.5, 129.0, 135.3,
6
]DMSO): δ
2
2
ArH), 7.10 (d, J = 8.0 Hz, 2 H, ArH), 7.28 (d, J = 8.0 Hz, 2 H,
=
3
2
1
3
ArH), 7.88 (d, J = 8.0 Hz, 2 H, ArH) ppm. C NMR (CDCl
= 20.6, 21.3, 36.3, 45.0, 47.0, 66.3, 126.3, 127.8, 129.3, 129.4, 132.7,
32.9, 133.1, 137.0, 138.8, 142.5, 164.5 ppm. MS (EI): m/z (%) =
3
): δ
2
2
2
1
3
3
6
]-
1
+
+
20 23 2 3
407 [M] (8), 169 (89), 105 (100), 86 (83). C H ClN O S (406.93):
1
65.0 ppm. MS (EI): m/z (%) = 282 [M] (24), 116 (100), 86 (91),
9 (50). C13 S (282.36): calcd. C 55.30, H 6.43, N 9.92;
calcd. C 59.03, H 5.70, N 6.88; found C 59.28, H 5.42, N 7.07.
7
18 2 3
H N O
found C 55.59, H 6.69, N 9.73.
N-[2-(4-Chlorophenyl)-1-morpholinoethylidene]-4-fluorobenzene-
1
4
-Methyl-N-(1-morpholino-2-phenylethylidene)benzenesulfonamide
sulfonamide (10l): Colorless powder (98%), m.p. 164–166 °C.
H
[
27]
6 3
NMR ([D ]DMSO): δ = 3.37 (br. s, 4 H, CH ), 3.59 (br. s, 2 H,
CH ), 3.71 (br. s, 2 H, CH ), 4.44 (s, 2 H, CH ), 7.21 (d, J = 8.0 Hz,
2 2 2
(
10f):
Colorless powder (83 %), m.p. 153–155 °C (ref. 148–
1
1
50 °C). H NMR ([D
), 3.54–3.56 (m, 2 H, CH
.44 (s, 2 H, CH ), 7.20–7.26 (m, 3 H, ArH), 7.29–7.34 (m, 4 H,
6
]DMSO): δ = 2.35 (s, 3 H, CH
3
), 3.28–3.35
(m, 4 H, CH
2
2
), 3.67–3.70 (m, 2 H, CH
2
), 2 H, ArH); 7.30–7.40 (m, 4 H, ArH), 7.87 (d, J = 8.0 Hz, 2 H,
1
3
4
2
6
ArH) ppm. C NMR ([D ]DMSO): δ = 35.6, 45.0, 47.6, 66.1,
1
3
116.2, 116.4, 129.1, 129.2, 130.3, 130.2, 132.0, 140.8, 162.9, 164.9,
ArH), 7.70 (d, J = 8.0 Hz, 2 H, ArH) ppm. C NMR ([D
DMSO): δ = 21.4, 36.0, 45.2, 47.3, 66.0, 126.3, 127.0, 128.4, 129.1,
6
]-
165.4 ppm. MS (EI): m/z (%) = 396 [M]+ (11), 159 (47), 150 (100),
1
2 3
29.7, 135.1, 141.7, 142.2, 165.4 ppm. MS (EI): m/z (%) = 358 95 (91). C18H18ClFN O S (396.86): calcd. C 54.48, H 4.57, N, 7.06;
+
found C 54.58, H 4.49, N 6.82.
[M] (4), 155 (61), 91 (100), 86 (87). C19
22 2 3
H N O S (358.45): calcd.
C 63.66, H 6.19, N 7.82; found C 63.45, H 6.09, N 7.60.
N-[2-(4-Chlorophenyl)-1-(piperidin-1-yl)ethylidene]-4-methylbenz-
enesulfonamide (10m): Yellow powder (86%), m.p. 125–127 °C. H
1
4
-Fluoro-N-(1-morpholino-2-phenylethylidene)benzenesulfonamide
1
(10g): Colorless powder (62%), m.p. 130–133 °C. H NMR ([D
6
]-
), 3.26–3.29 (m, 2 H, CH
CH ), 7.11 (d, J = 8.0 Hz, 2 H, ArH), 7.20–7.26 (m, 4 H, ArH),
6
7.80 (d, J = 8.0 Hz, 2 H, ArH) ppm. C NMR ([D ]DMSO): δ =
NMR (CDCl
3
): δ = 1.53–1.60 (m, 6 H, CH
2
), 2.39 (s, 3 H, CH
3
),
DMSO): δ = 3.32–3.34 (m, 4 H, CH
2
), 3.50–3.62 (m, 2 H, CH
2
2
), 3.72–3.77 (m, 2 H, CH
2
), 4.38 (s, 2 H,
3
.66–3.72 (m, 2 H, CH
2
), 4.44 (s, 2 H, CH
2
), 7.13–7.41 (m, 7 H,
]DMSO): δ =
5.5, 44.8, 46.8, 66.5, 115.7, 115.9, 126.7, 127.8, 128.6, 128.7, 134.3,
40.3, 162.3, 164.8, 164.9 ppm. MS (EI): m/z (%) = 362 [M]+ (3),
59 (47), 116 (86), 86 (100). C18
9.65, H 5.28, N 7.73; found C 59.42, H 5.59, N 7.91.
2
ArH), 7.80–7.90 (m, 2 H, ArH) ppm. 13C NMR ([D
13
6
3
1
1
5
20.8, 23.1, 24.8, 35.0, 45.3, 47.3, 125.6, 128.4, 129.1, 131.0, 141.3,
141.5, 166.5 ppm. MS (EI): m/z (%) = 390 [M]+ (2), 155 (25), 91
H
2 3
19FN O
2 2
S (362.42): calcd. C (52), 84 (100). C20H23ClN O S (390.93): calcd. C 61.45, H 5.93, N
7.17; found C 61.58, H 5.69, N 6.92.
N-(1-Morpholino-2-phenylethylidene)benzo[c][1,2,5]thiadiazole-4-
N-[2-(4-Methoxyphenyl)-1-(4-methylpiperazin-1-yl)ethylidene]-
4-methylbenzenesulfonamide (10n): Yellow powder (79%), m.p. 103–
1
sulfonamide (10h): Colorless powder (55%), m.p. 123–126 °C.
H
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5